Acurx Pharmaceuticals
ACXP
ACXP
32 hedge funds and large institutions have $1.33M invested in Acurx Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $1.36M → $1.33M (-$29.9K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
32
Holding in Top 10
–
Calls
$33K
Puts
$29K
Top Buyers
| 1 | +$551K | |
| 2 | +$35.6K | |
| 3 | +$35.4K | |
| 4 |
Renaissance Technologies
New York
|
+$31.3K |
| 5 |
OBGC
O'Brien Greene & Co
Media,
Pennsylvania
|
+$30.6K |
Top Sellers
| 1 | -$1M | |
| 2 | -$196K | |
| 3 | -$35.7K | |
| 4 |
SFA
Semmax Financial Advisors
Winston Salem,
North Carolina
|
-$23.4K |
| 5 |
BlackRock
New York
|
-$16.9K |
